Retinal and Lens Degeneration in New Zealand White Rabbits Administered Intravitreal TSG-6 Link Domain-Rabbit FAb Fusion Proteins. (April 2021)
- Record Type:
- Journal Article
- Title:
- Retinal and Lens Degeneration in New Zealand White Rabbits Administered Intravitreal TSG-6 Link Domain-Rabbit FAb Fusion Proteins. (April 2021)
- Main Title:
- Retinal and Lens Degeneration in New Zealand White Rabbits Administered Intravitreal TSG-6 Link Domain-Rabbit FAb Fusion Proteins
- Authors:
- Laing, Steven T.
Tassew, Nardos
Tesar, Devin
Wang, Yue
Crowell, Susan R.
Gray, Julia
Kwong, Mandy
Loyet, Kelly M.
Andaya, Roxanne
Kusi, Aija
Kelley, Robert F. - Other Names:
- Ramos Meg Ferrell guest-editor.
Schafer Kenneth guest-editor.
Sorden Steven guest-editor. - Abstract:
- Fusion of biologic therapeutics to hyaluronic acid binding proteins, such as the link domain (LD) of Tumor necrosis factor (TNF)-Stimulated Gene-6 (TSG-6), is expected to increase vitreous residence time following intravitreal injection and provide for long-acting delivery. The toxicity of a single intravitreal dose of free TSG-6-LD and fusion proteins of TSG-6-LD and a nonbinding rabbit antibody fragment (RabFab) were assessed in New Zealand White rabbits. Animals administered free TSG-6-LD exhibited extensive lens opacities and variable retinal vascular attenuation, correlated with microscopic findings of lens and retinal degeneration. Similar but less severe findings were present in animals dosed with the RabFab-TSG-6-LD fusion proteins. In-life ocular inflammation was noted in all animals from 7-days postdose and was associated with high anti-RabFab antibody titers in animals administered fusion proteins. Inflammation and retinal degeneration were multifocally associated with evidence of retinal detachment, and hypertrophy and migration of vimentin, glial fibrillary acidic protein, and glutamine synthetase positive Müller cells to the outer nuclear layer. Further assessment of alternative hyaluronic acid binding protein fusions should consider the potential for retinal degeneration and enhanced immune responses early in development.
- Is Part Of:
- Toxicologic pathology. Volume 49:Number 3(2021)
- Journal:
- Toxicologic pathology
- Issue:
- Volume 49:Number 3(2021)
- Issue Display:
- Volume 49, Issue 3 (2021)
- Year:
- 2021
- Volume:
- 49
- Issue:
- 3
- Issue Sort Value:
- 2021-0049-0003-0000
- Page Start:
- 634
- Page End:
- 646
- Publication Date:
- 2021-04
- Subjects:
- drug development -- immunohistochemistry -- mechanisms of toxicity -- ocular toxicity -- retina -- long-acting delivery -- hyaluronic acid-binding proteins
Pathology -- Periodicals
Toxicology -- Periodicals
Pathology
Toxicology
615.9 - Journal URLs:
- http://tpx.sagepub.com/ ↗
http://online.sagepub.com/ ↗ - DOI:
- 10.1177/0192623320969124 ↗
- Languages:
- English
- ISSNs:
- 0192-6233
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8873.015000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 15243.xml